Annual Conference
Therapeutic innovation with combined products – better healthcare to patients
27 September 2023 – Basel, Switzerland
Advanced Program
THE ADVANCED CONFERENCE PROGRAM (27 SEPTEMBER 2023, MÖVENPICK HOTEL BASEL)
Welcome and introduction
Welcome and introduction
Shayesteh Fürst-Ladani (MPP President, SFL)
Ruth Foster (Chair of MPP2023 Program Committee, MSD)
Lukas Engelberger (Government of Canton Basel-Stadt, Switzerland)
Keynote address
Keynote address
Speaker TBC
Panel discussion
Opening statements followed by a moderated debate and Q&A
The panel discussion will gather representatives from the industry, regulatory authorities and a patient organization to discuss the regulation of combined products on a global level.
Moderation: Shayesteh Fürst-Ladani (MPP President, SFL)
Panelists
David Haerry (EATG)
John Weiner (US FDA)
Michael Berntgen (EMA)
MTE (invited)
MHRA (invited)
Swissmedic (invited)
European Commission (invited)
Session
Digital health policy: current status and outlook
Short presentations followed by a Q&A
This session will revolve around digital health policy. Featuring speakers from the industry, authorities, the session will explore defining policy developments in digital health and provide an outlook on expectations and challenges in this area.
Chairs: Ruth Foster (MSD) & Nathalie Schober-Ladani (SFL)
Speakers
Petra Leroy Cadova (DG RTD)
Samuel Gavillet (SFL)
US FDA (invited)
EMA (invited)
European Commission (invited)
Session
Regulatory assessment of combined products: experience in dialogue between stakeholders
Short presentations followed by a Q&A
In this session, representatives from notified bodies and the industry will exchange perspectives on the interactions between the different stakeholders for the assessment of combined products and potential solutions to improve the communication and facilitate access to innovative technologies.
Chairs: Mike Wallenstein (Novartis) & Christiana Hofmann (Anteris by Kymanox)
Speakers
Ilona Reischl (AGES)
Team-NB (invited)
Patients (invited)
Session
Companion diagnostics as enablers of innovative treatment
Short presentations followed by a Q&A
The goal of this session is to present opportunities and challenges in the clinical development and regulation of companion diagnostics. The session will explore the different perspectives on clinical development and regulation of companion diagnostics through the lenses of academia, industry and regulators.
Chairs: Florian Wildenhahn (Roche) & Marisa Papaluca (Imperial College London)
Speakers
Prof. Antoni Bayes-Genis (Institut del Cor)
Falk Ehmann (EMA)
Novartis (invited)
EU IVD Expert Panel (invited)
Wrap-up and closing
Wrap-up and closing
Shayesteh Fürst-Ladani (MPP President, SFL)
Ruth Foster (Chair of the MPP2023 Program Committee, MSD)
Questions regarding the event organization
Questions regarding the conference program
Our Sponsors
Our Media Partner